Groundbreaking New OA Treatment That Breaks the Inflammatory Cycle
The management of the chronic pain and inflammation of canine osteoarthritis is a common and significant challenge for practitioners. Come learn about an exciting new transformational treatment that uses the novel radioisotope tin 117m (Synovetin OA™) to safely target the source of inflammation for long-lasting results
- Participants will learn:
- The role of synovitis in OA, the science behind the micro-environment of the joint and synovium as a target for therapeutic intervention and long term results.
- The attributes and mechanism of action of the highly innovative radioisotope tin 117m, and the long history of safe use of radioisotopes to treat arthritis in people.
- The outstanding efficacy, safety, and overall treatment experience using Synovetin OA from a lead clinical investigator.